Our Mission: Improving and Extending the Lives of Patients with Cancer
  
 
 About Celator®   |   Products   |   CombiPlex®   |   Publications   |   News & Events   |   Contact   |   Home
  Management      Board of Directors      Scientific Advisory Board      Investors      Business Development      Careers
 

Investors

Principal investors in Celator include:

                            

Domain Associates L.L.C.

Ventures West Management, Inc.

Quaker BioVentures

TL Ventures

GrowthWorks Capital, Ltd.

BDC Capital
 

 

 


Celator is pioneering a new approach to combination chemotherapy based on synergistic drug ratios.

 

 

 

 

 

  
© 2009 Celator Pharmaceuticals, Inc. All rights reserved. Celator®, Celator Pharmaceuticals®, the Celator logo and CombiPlex® are registered trademarks of Celator Pharmaceuticals, Inc. Contact webmaster.